Evidence map›Paper›PMID 35192340›Full record

ArticleACS sensors2022

Multiplex, Real-Time, Point-of-care RT-LAMP for SARS-CoV-2 Detection Using the HFman Probe.

Yajuan Dong, Yongjuan Zhao, Shenwei Li, Zhenzhou Wan, Renfei Lu, Xianguang Yang, Guoying Yu, Julien Reboud, Jonathan M Cooper, Zhengan Tian and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ACS sensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Point of Care Testing and Recombinase Polymerase Amplification.Journal of clinical laboratory analysis · 2026
    Article
  3. Article
  4. Simultaneous detection of SARS-CoV-2 proteins and nucleic acids by coupling PNIPAM with circle-to-circle amplification.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Yajuan DongCollege of Life Sciences, Henan Normal University, Xinxiang 453007, China.
Yongjuan ZhaoShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Shenwei LiShanghai International Travel Healthcare Center, Shanghai 200335, China.
Zhenzhou WanMedical Laboratory of Taizhou Fourth People's Hospital, Taizhou 225300, China.
Renfei LuClinical Laboratory, Nantong Third Hospital Affiliated to Nantong University, Nantong 226006, China.
Xianguang YangCollege of Life Sciences, Henan Normal University, Xinxiang 453007, China.ORCID 0000-0002-7617-2816
Guoying YuCollege of Life Sciences, Henan Normal University, Xinxiang 453007, China.
Julien ReboudDivision of Biomedical Engineering, University of Glasgow, G12 8LT Glasgow, U.K.ORCID 0000-0002-6879-8405
Jonathan M CooperDivision of Biomedical Engineering, University of Glasgow, G12 8LT Glasgow, U.K.ORCID 0000-0002-2358-1050
Zhengan TianShanghai International Travel Healthcare Center, Shanghai 200335, China.
Chiyu ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.ORCID 0000-0001-8735-9857
Shanghai Public Health Clinical Center · CNHenan Normal University · CNShenzhen International Travel Health Care Center · CNUniversity of Glasgow · GBNantong University · CNTaizhou Fourth People's Hospital · CN

Funding

Medical Research Council MR/V035401/1
6 · The paper itself

Abstract

Viral evolution impacts diagnostic test performance through the emergence of variants with sequences affecting the efficiency of primer binding. Such variants that evade detection by nucleic acid-based tests are subject to selective pressure, enabling them to spread more efficiently. Here, we report a variant-tolerant diagnostic test for SARS-CoV-2 using a loop-mediated isothermal nucleic acid-based amplification (LAMP) assay containing high-fidelity DNA polymerase and a high-fidelity DNA polymerase-medicated probe (HFman probe). In addition to demonstrating a high tolerance to variable SARS-CoV-2 viral sequences, the mechanism also overcomes frequently observed limitations of LAMP assays arising from non-specific amplification within multiplexed reactions performed in a single "pot". Results showed excellent clinical performance (sensitivity 94.5%, specificity 100%,

Indexed as

COVID-19SARS-CoV-2COVID-19 TestingHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesPoint-of-Care SystemsRNA, ViralSensitivity and SpecificityRNA, ViralCOVID-19/SARS-CoV-2HFman probehigh-fidelity DNA polymerasemultiplex LAMPnon-specific amplificationpoint-of-care testing (POCT)

Identifiers

PMID35192340
PMCPMC8887655
OpenAlexW4213452246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.